Aims & Scope – Current Respiratory Medicine Reviews

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Latest Issue: Volume 18 , Issue 2 , 2022

Aims & Scope

Current Respiratory Medicine Reviews publishes original research papers, frontier reviews/mini-reviews, drug clinical trial studies and guest-edited issues, dedicated to clinical research on all the latest advances in respiratory diseases and their related areas (i.e., pharmacology, pathogenesis, clinical care and therapeutics). The journal is essential reading for all clinicians and researchers in the fields of respiratory medicine and associated specialties. In addition, it also covers a wide variety of topics that show the relationship between respiratory and lung diseases, as well as cardiovascular and thoracic diseases. Read now:

Recently Published Issue of the Journal Cardiovascular & Hematological Agents in Medicinal Chemistry

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.

Following are the articles from the journal Cardiovascular & Hematological Agents in Medicinal Chemistry, 12 Issue 2:

Articles:Editorial (Thematic Issue Title: Myocardial Cell Death: Molecular Mechanisms & Drug Targets)

Author(s): Rajesh Mohanraj

Articles:Role of α -Crystallin B in Regulation of Stress Induced Cardiomyocyte Apoptosis

Author(s): Subhalakshmi Ganguly, Arkadeep Mitra and Sagartirtha Sarkar

Articles:Early Growth Response-1 (EGR-1) – A Key player in Myocardial Cell Injury

Author(s): Nirupama Ramadas, Barathi Rajaraman, Ashok A. Kuppuswamy and Srinivasan Vedantham

Articles:Targeting Apoptotic Pathways in Myocardial Infarction: Attenuated by Phytochemicals

Author(s): Shaikh Haidarali, Chandragouda R. Patil, Shreesh Ojha, Rajesh Mohanraj, Dharamvir S. Arya and Sameer N. Goyal

Articles:Evaluation on Clot Buster Activity of Staphylokinase from Staphylococcus sp.

Author(s): V. Mohanasrinivasan, C. Subathra Devi, Sukanya Saha, Lubbnaz Nagarchi, B. Vaishnavi and S. J. Naine

Articles:Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases

Author(s): Rami A. Al-Horani

Articles:Therapeutic Potential of Coagonists of Glucagon and GLP-1

Author(s): Vishal J. Patel, Amit A. Joharapurkar, Samadhan G. Kshirsagar, Kartikkumar N. Patel, Gaurang B. Shah and Mukul R. Jain

For details, please visit:

Bentham Open Access Article


The article entitled Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation’ in the journal Protein & Peptide Letters, 2014, 21, 1273-1281, is now open for all to view and access.

For article Information, please visit:
For journal information, please visit:

Bentham Open Access Article


The article entitled, ‘Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation’ in the journal Cardiovascular & Hematological Agents in Medicinal Chemistry, 2014, 12, 3-8, is now open for all to view and access.

For article Information, please visit:

For journal information, please visit:

World Heart Day – Inforgraphics

Celebrate ‘World Heart Day’ with Bentham Science Publishers! Learn All You Need To Know About Protecting Your Heart Through This Inforgraphics:

heart day

To access journals on Cardiology:
To access eBooks on Cardiology:

#WorldHeartDay #Heart #cardiovascular #cardiology


Source: World Heart Association

High-Protein Diet Helps Diabetics

Obese people with diabetes are able to lose weight on high-protein diets and see improvement in both cardiovascular and renal health, without facing increased risks, according to new research reported by Medical Xpress

The study, conducted by University of Adelaide PhD student Eva Pedersen, compared the effects of a high-protein and standard diet in a year-long study involving 45 obese people with Type 2 diabetes.

The results show that weight loss achieved by both diets resulted in a range of benefits for the participants.
“High-protein diets are commonly used in our community, but concerns have been raised about the potential harmful effects of these diets on diabetic people’s renal function, which is often already compromised due to their condition,” said Peter Clifton, affiliate professor at the University of Adelaide’s School of Medicine and Eva Pedersen’s supervisor.

Within the first six months of the study, both diets helped the participants to lose weight, with almost 9 percent of body weight lost by those on the high-protein diet and more than 6 percent by those on the standard diet.

“Far from seeing any problems caused by the high-protein diet, the participants’ weight loss resulted in improvements to their renal health, as well as to their overall cardiovascular health and the control of their blood-sugar levels,” said Clifton.

Read Latest Breaking News from 

%d bloggers like this: